Combination chemotherapy and renal enzyme and protein excretion in patients with breast cancer

[1]  F. Cognetti,et al.  Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. , 1995, Journal of the American College of Surgeons.

[2]  B. Gusterson,et al.  High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Rodger,et al.  ABC of Breast Diseases: Metastatic breast cancer , 1994, BMJ.

[4]  F. Gilbert,et al.  Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study. , 1994, British Journal of Cancer.

[5]  U. Burchardt,et al.  Urinary Enzymes in Clinical and Experimental Medicine , 1992 .

[6]  B. Asselain,et al.  Neoadjuvant chemotherapy in operable breast cancer. , 1991, European journal of cancer.

[7]  L. Norton,et al.  Metastatic breast cancer. Length and quality of life. , 1991, The New England journal of medicine.

[8]  P. Bach.  Nephrotoxicity: Mechanisms, Early Diagnosis, and Therapeutic Management , 1991 .

[9]  B. Asselain,et al.  Neoadjuvant chemotherapy in operabla breast cancer , 1991 .

[10]  F. Blanchet,et al.  Renal functional reserve. , 1989, Toxicology letters.

[11]  V. Ferrans,et al.  Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. , 1988, The New England journal of medicine.

[12]  M. Erecińska,et al.  Adriamycin-induced lipid peroxidation in mitochondria and microsomes. , 1988, Biochemical pharmacology.

[13]  G. Schwartz,et al.  Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast. , 1987, Archives of surgery.

[14]  A. Sheil,et al.  Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine. , 1985, Kidney international.

[15]  W. Guder,et al.  Enzyme distribution along the nephron. , 1984, Kidney international.

[16]  K. Jung,et al.  An optimized assay of alanine aminopeptidase activity in urine. , 1980, Clinical chemistry.

[17]  L. Borthwick,et al.  N-Acetyl-beta-D-glucosaminidase levels and diabetic microangiopathy. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[18]  S. Rosenberg,et al.  Clinical course and management of accidental adriamycin extravasation , 1977, Cancer.

[19]  T. Priestman.  Cancer chemotherapy: An introduction , 1977 .

[20]  R. Pattillo,et al.  Skin ulcers due to adriamycin , 1976, Cancer.

[21]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[22]  J. Robbins,et al.  Automation of a quantitative immunochemical microanalysis of human serum transferrin: a model system. , 1970, Clinical chemistry.

[23]  R. Silvestrini,et al.  [Biological activity of adriamycin in vitro]. , 1970, Tumori.

[24]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .

[25]  H. Grady,et al.  Determination of creatinine by means of automatic chemical analysis. , 1960, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists.